IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced the company will present a poster titled "Selective peroxisome proliferator-activated receptor (PPAR) delta (?) agonist, mavodelpar, improves cellular bioenergetics in fibroblasts from patients with mitochondrial complex I deficiency" at the following upcoming scientific meetings.
PittGene Meeting
Date: Wednesday, October 25, 2023, at 2:00-2:45pm ET
Location: University Club at University of Pittsburgh, Pittsburgh, PA
Presenter: Bianca Seminotti, PhD
Translational Research in Mitochondria, Metabolism, Aging and Disease (TRiMAD) Meeting 2023
Date: Monday, November 6, ...